MedTrace Logo

Study of The Effects of Testosterone in Frail Elderly Men

NCT00190060 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 262

Last updated 2018-08-03

No results posted yet for this study

Summary

The study aims to determine the effects of testosterone on muscle function, mobility, activities of daily living and overall quality of life

Conditions

Interventions

DRUG

Transdermal testosterone gel (Testogel 1% )

Transdermal testosterone gel (Testogel 1% ), 50 mg/d for 6 months

DRUG

Matched transdermal placebo gel

Matched transdermal placebo gel, 50mg/d for 6 months

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Bayer

    collaborator INDUSTRY

  • Manchester University NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Professor Frederick CW Wu, MD, FRCP · Central Manchester and Manchester Children's University Hospitals Trust & The University of Manchester

  • Dr Martin Connolly, MD, FRCP · Central Manchester and Manchester Children's University Hospitals Trust

  • Professor JA Oldham, PhD · The University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00190060 on ClinicalTrials.gov